Philippe Amouyal

Insider Reports History

Entity
Individual
Location
C/O Cava Group, Inc., 14 Ridge Square Nw, Suite 500, Washington, DC
Signature
/s/ Kenneth Robert Bertram, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philippe Amouyal:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CAVA GROUP, INC. Director Common Stock 16.3K $1.55M $95.28 Jun 20, 2024 Direct
LEXICON PHARMACEUTICALS, INC. Director Common Stock 248K $651K $2.62 Apr 28, 2024 Direct
LEXICON PHARMACEUTICALS, INC. Director Restricted Stock Units 36.8K $96.4K $2.62 May 13, 2024 Direct
LEXICON PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 44.9K May 13, 2024 Direct

Insider Reports Filed by Philippe Amouyal

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CAVA CAVA GROUP, INC. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
LXRX LEXICON PHARMACEUTICALS, INC. May 13, 2024 2 $0 4 May 13, 2024 Director
LXRX LEXICON PHARMACEUTICALS, INC. Apr 28, 2024 2 $0 4 Apr 29, 2024 Director
CAVA CAVA GROUP, INC. Nov 17, 2023 1 $332K 4 Nov 21, 2023 Director
LXRX LEXICON PHARMACEUTICALS, INC. Nov 13, 2023 1 $202K 4 Nov 14, 2023 Director
CAVA CAVA GROUP, INC. Jun 20, 2023 1 $0 4 Jun 22, 2023 Director
CAVA CAVA GROUP, INC. Jun 15, 2023 0 $0 3 Jun 15, 2023 Director
LXRX LEXICON PHARMACEUTICALS, INC. May 21, 2023 2 $0 4 May 22, 2023 Director
LXRX LEXICON PHARMACEUTICALS, INC. Apr 28, 2023 2 $0 4 Apr 28, 2023 Director
LXRX LEXICON PHARMACEUTICALS, INC. May 21, 2022 2 $0 4 May 23, 2022 Director
LXRX LEXICON PHARMACEUTICALS, INC. Apr 30, 2022 2 $0 4 May 2, 2022 Director